Graphite electrodes are modified with a redox polymer, [Os(4,4ʹ-dimethoxy-2,2ʹ-bipyridine) 2 (polyvinylimidazole) 10 showing promise for in vivo or ex vivo power generation under these conditions.
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Introduction
Enzymatic fuel cells (EFCs) are electrochemical devices that utilise biocatalysts for conversion of chemical energy to electrical energy [1] [2] [3] . In EFCs, enzymes replace the conventional metal catalyst providing improved specificity towards reactions they catalyse [1, 4, 5] allowing for development of miniaturised, potentially implantable or portable, membrane-less EFCs through the elimination of the need for half-cell compartments and separating membranes [2] [3] [4] 6] . Enzyme catalysts operate under relatively mild conditions (20-40 °C, neutral pH), making them attractive for power generation in vivo utilising fuels and oxidants such as glucose and oxygen present in the bloodstream [7] [8] [9] .
Redox polymer matrices for enzyme electrodes improve shuttling of electrons between active site and electrode surface, making electron transfer independent of orientation or proximity of the enzyme active site to the electrode surface, in comparison to that for direct electron-transfer mechanisms between enzyme and electrode [5, 10] . Current output from enzyme electrodes depends on selection of mediator with appropriate structure and suitable redox potential for rapid electron transfer between enzyme active site and electrode surface [11, 12] . Osmium-based mediators have been widely used [2, [13] [14] [15] owing to the ability to modulate the mediator redox potential of the central Os metal by using coordinating ligands, the relative stability of the resulting complexes in the Os(II)/Os(III) states, and because the hydrogel characteristics of redox-polymer films permit rapid mass and charge transport, thus generating substantial current signals [2, 16, 17] . The inclusion of multi-walled carbon nanotubes (MWCNTs) is one route towards improving glucose oxidation currents for enzyme electrodes prepared by crosslinking the nanomaterial with enzymes and osmium-based redox mediators [8, [18] [19] [20] , attributed to improved retention of enzyme activity [21, 22] . Tsujimura et al. reported on similar bio anodes with magnesium oxide-templated mesoporous carbon as a support structure for hydrogels consisting of FADGDH and redox polymer [23] .
We here report on optimisation of an enzyme electrode for glucose oxidation based on coimmobilisation of an [Os(4,4'-dimethoxy-2,2'-bipyridine) 2 (poly-vinyl imidazole) 10 Cl] + (Os(dmobpy)PVI) polymer, selected due to its lower redox potential, −0.02 V vs Ag/AgCl (3 M KCl), compared to our previous studies using [Os(4,4'-dimethyl-2,2'-bipyridine) 2 (polyvinylimidazole) 10 Cl] + (Os(dmbpy)PVI), and an enzyme [22] . A flavin adenine dinucleotide dependent glucose dehydrogenase (FADGDH) enzyme is selected over glucose oxidase due to its lack of reactivity with oxygen as co-substrate, for operation of an EFC in a membraneless glucose/oxygen solution. Tremey et al. have shown improved performance of glucose oxidase in the presence of oxygen through mutation of the enzyme [24] .
Enzyme electrode current output is dependent on the relative amount of components (osmium redox polymer, enzyme and MWCNTs) and optimisation is usually undertaken by varying one factor at a time. Kumar et al. [25] used a response surface design of experiment (DoE) methodology to optimise components used to construct enzyme electrodes. They reported a 32% increase in glucose oxidation current in comparison to that observed for enzyme electrodes optimised by varying of one factor at a time [25, 26] .
Here we develop and validate a DoE methodology to optimise the enzyme electrode performance for current output under pseudo-physiological conditions (5 mM glucose, 50 mM phosphate buffered saline, PBS, pH 7.4, 37 °C). The DoE-optimised enzyme electrodes provide >50% improvement of glucose oxidation current density in absence of oxygen compared to previously reported values with the same components optimised using onefactor-at-a-time approach (OFAT) [22] . Tailoring of dropcoat amounts guided by contour plots from DoE software to include a lower amount of enzyme provides similar current density at 5 mM glucose concentrations while saving on enzyme amount required.
Application of the selected anodes in membrane-less enzymatic fuel cells is demonstrated by connection to an oxygen-reducing Myrothecium verrucaria bilirubin oxidase-based cathode, operating in pseudo-physiological buffer, artificial plasma and human plasma respectively, showing promise for in vivo or ex vivo power generation under these conditions.
Experimental

Materials
All chemicals and biochemicals were purchased from Sigma-Aldrich, unless otherwise stated. 
Electrochemical measurements
Electrochemical tests were conducted using a CH Instrument 1030 multichannel potentiostat in a three electrode cell containing 50 mM phosphate buffer saline (PBS, 150 mM NaCl) pH 7.4, at 37 °C as electrolyte and a Ag/AgCl (3 M KCl) reference electrode, a graphite working electrode and a platinum mesh counter electrode (Goodfellow).
Fuel cell assembly and testing
The EFCs were constructed by combining anode enzyme electrodes with a previously described cathode [29] , prepared as described for anode enzyme electrodes except using 
Results and Discussion
Enzyme electrodes were initially modified through the co-immobilisation of is similar to values obtained from previous report [19, 21] .
Design of Experiment
For the optimisation of bioanodes, a DoE based on response surface factorial Box-Behnken Design (BBD) with a three level factorial design is used to evaluate the main effect and interaction between the MWCNTs, osmium redox polymer and FADGDH components required to prepare glucose-oxidising enzyme electrodes. The Box-Behnken design requires an experiment number according to N = 2k (k − 1) + C 0 [34] , where k is the number of factors, and C 0 is the number of central points. The 16 run (with n=3 electrodes used to determine the current density for each run) experimental design is used to demonstrate the relative significance of the bioanode components and seek to enhance current density in pseudo-physiological conditions, compared to OFAT approach. The range and level of components investigated is given in Table 1 and runs and results used to build the model given in Table 2 . Table 1 The factors and levels selected to vary for DoE optimisation of performance of enzyme electrode. 
where is the predicted current response value in mA cm −2 , 1 , 2 and 3 are the 
In this response model, analysis of variance (ANOVA) is used for statistical testing and the data extracted demonstrates whether or not the model is statistically significant [36] . The low F-value (19.43) and p-value (0.0009) evaluated suggests that the model is statistically significant, as the higher the values, the more likely the rejection of the null hypothesis that the data show no variation. Furthermore, a coefficient of determination (R 2 ) between predicted and observed responses was evaluated to be 0.97, and when the amount of variation in the model was adjusted the measure of the adjusted R 2 (Adj R 2 ) value is 0.92, thereby suggesting significant correlation. These results are similar to those observed previously by
Kumar et al. [25] for enzyme electrodes prepared by co-immobilisation of MWCNTs, GOx, osmium redox complex and carboxymethylated dextran on graphite and current measured in physiological conditions.
Model Validation and Optimised Enzyme Electrode
In order for a system to be optimised, it is imperative to demonstrate that the model is a reasonable representation of the actual system and that it reproduces system behaviour with enough fidelity to satisfy analysis objectives. Model validation was tested based on values randomised by the model together with their predicted results under pseudo-physiological conditions (5 mM glucose, 50 mM phosphate buffered saline, PBS, pH 7.4, 37 °C), with the results presented in Table 3 . A plot of predicted current density versus observed current density delivers a correlation (R 2 ) of 0.87 suggesting that the model is valid.
Table 3
Model validation comparing predicted versus actual (at 0.15 V) amperometric current density response for enzyme electrodes under pseudo-physiological conditions. Conditions as in Table 2 . Errors are from the predicted standard deviation from the model for the predicted current density or from the standard deviation of 4 electrodes for the actual current density.
Os(dmobpy) PVI Following the response achieved from enzyme electrodes prepared using this model, the FADGDH and MWCNTs amounts were shown to be the main factors contributing to the enhanced current densities (see Figure 3) . A previous report has shown that the addition of MWCNTs on the enzyme electrode increased the amount of redox polymer that is coimmobilised and electronically coupled within the enzyme films leading to greater current response [21] . Variation in the amount of the Os(dmobpy)PVI, once added, have the smallest effect of the three components.
The DoE optimum component amounts, based on maximising the predicted current density using equation 2, are 80 µg redox polymer, 410 µg MWCNTs and 100 µg FADGDH, predicted to deliver a current density of 0.93 ± 0.07 mA cm −2 in PBS containing 5 mM
glucose. An actual measured current density of 1.22 ± 0.1 mA cm −2 (n=4) is obtained for the enzyme electrodes prepared using the DoE determined optimum component amounts. This represents a 52 % increase on the response, under similar conditions, for enzyme electrodes (0.8 mA cm −2 ) using the same components and a OFAT method of optimisation of response [22] .
The electrochemical response for the optimised enzyme electrodes is shown in Figure 1 and 2, demonstrating a maximum current density j max of 3.41 ± 0.21 mA cm −2 for the electrode under glucose saturation (100 mM) conditions in comparison to previously reported j max of 2.30 ± 0.31 mA cm −2 for the same enzyme electrode using the OFAT optimised component amounts.
Prior to incorporation of the optimised anode in a fuel cell setup a further round of testing was conducted based on consideration of the contour plot generated for FADGDH versus MWCNTs levels ( Figure 3 ). The consideration of the contour plots and predicted response by variation in FADGDH and MWCNT amounts (Table 4) demonstrates that little variation in current density is observed in the region of 0.5 to 1.0 FADGDH and MWCNT levels ( Figure   4 ). Thus the selected amounts for each of these factors can be altered depending on other factors to be considered in manufacturing enzyme electrodes, such as cost of materials or ease of electrode preparation. 
Operation in Oxygen
The selected bioanodes were further tested in the presence of oxygen in order to evaluate the effect of oxygen on these enzyme electrodes for eventual application in membrane-less EFCs.
A 17% decrease in current density is observed for the enzyme electrode operating in 5 mM glucose concentration in the presence of oxygen, compared to the absence of oxygen, Figure   4 . The decrease in glucose currents in the presence of oxygen suggests that molecular oxygen is reduced by the osmium redox polymer, which in turn decreases the amount of osmium redox centres that can be accessed by the electrons from glucose substrate, thus decreasing current density in the presence of oxygen, as reported on recently [16, 22, 37] .
Figure 4
Glucose oxidation current density observed as a function of glucose concentration for the selected enzyme electrode (Os(dmobpy)PVI (80 µg) co-immobilised with FADGDH (100 µg) and MWCNTs (410 µg) measured in PBS at 37 °C with stirring at 150 rpm at an applied potential of 0.15 V, for enzyme electrodes in the presence (red) and absence of oxygen (blue).
Enzymatic Fuel Cell Testing
Enzymatic fuel cells were assembled based on the utilisation of glucose as fuel and oxygen as oxidant for testing under pseudo-physiological conditions using anodes prepared by coimmobilisation of Os(dmobpy)PVI redox polymers with FADGDH and MWCNTs using amounts optimised from the DoE approach. Enzyme electrodes chosen as cathodes are based on previous reports [22, 29] of Os(bpy)PVI redox polymer co-immobilised with MvBOd and 78% w/w MWCNTs on graphite electrodes of the same geometric area as the anodes.
A potential application for EFC system is to power implantable medical devices via the oxidation of glucose as fuel and the reduction of oxygen as oxidant available in the bloodstream. Assembled EFC were therefore first tested in pseudo-physiological buffer conditions containing 0.2 mM O 2 . For these EFCs, average power density of 270 ± 15 µW cm −2 is achieved ( Figure 5 ) with a maximum power output of 285 µW cm −2 . The polarisation curves ( Figure 6 ) for enzyme electrodes and the assembled EFC indicate that the cathode current density limits power produced. The maximum power density is observed at ~0.3 V similar to that obtained previously [22] . Others have reported on a membrane-less EFC operating at higher cell voltages. For example, Kim et al. [38] report on an EFC producing a power density of 50 µW cm −2 at a 0.5 V cell voltage under physiological conditions (air saturated pH 7.4, 140 mM NaCl, 37.5 °C in 15 mM glucose concentration) with the increased voltage due to the differences in redox potential of the osmium redox polymers selected. Due to differences in operating conditions, such as pH, glucose concentrations and also electrode preparation methodologies, comparison with other EFC results has proven difficult.
Nonetheless our results compare well with those reported on for similar systems. For example, Soukharev et al. [39] report an EFC using GOx and a fungal laccase, coimmobilised with osmium redox polymers on 7 µm diameter, 2 cm long carbon fibres, produces a power density of 350 µW cm −2 in 15 mM glucose solutions. However, when the same EFC is tested for operation in 5 mM glucose solutions and using GOx sourced from Penicillium pinophilum, a power density of 280 µW cm −2 is achieved [40] similar to the maximum power density obtained in Figure 6 . More recently MacAodha et al. [29] report on an EFC operating in pseudo-physiological conditions using a GDH enzyme but coimmobilised with Os(dmbpy)PVI redox polymer at the anode while Myceliophthora thermophila laccase enzyme was used at the biocathode that produced a power density in in 5 mM glucose solutions of 145 µW cm −2 . To verify that EFC can produce power under more realistic sample conditions the assembled EFCs were operated in an artificial plasma recipe solution [30] , providing an average power density of 109 ± 37 µW cm −2 ( Figure 5 ) with a maximum power output of 146 µW cm −2 . Maximum power output produced in artificial plasma is approximately half that observed for the same EFC operating in PBS: a similar change has been reported by MacAodha et al. achieving a power density of 60 µW cm −2 [29] . This difference in power output observed between artificial plasma and PBS is probably due to the presence of antioxidants and enzyme-inhibiting compounds in the artificial plasma solutions [41] [42] [43] . In addition, an oxygen concentration of only 0.06 mM was measured in the plasma, achieved by oxygen sparging through the solution, compared to 0.125 mM measured in the PBS. To evaluate the factors limiting the power output for the EFCs, polarisation curves at the anode and cathode enzyme electrodes from the 1 mV s −1 slow scan CVs can be combined to model cell polarisation curves for each EFC (see Figure 6 ). The polarisation curves indicate that the current at the cathode (as cathode and anode areas are the same) limits power produced at the assembled fuel cell under these conditions.
Further experiments were conducted to test for EFC operation in human plasma in an attempt to evaluate the effect of the deployment in real solutions. The human plasma sample was used as purchased. An average power density of 53 ± 9 µW cm −2 ( Figure 6 ) with a maximum power output of 60 µW cm −2 is achieved for the EFC this sample. The maximum power output observed for human plasma is approximately half of that observed in artificial plasma. This difference is possibly due to the fact that blood plasma contains additional components such as blood clotting factors, lipids, hormones, enzymes, antibodies, and other proteins/components not present in artificial plasma, some of which are enzyme-inhibiting [44] . Although the oxygen concentration measured in human plasma is 0.1 mM and similar to a previous reported value [43, 45] , the power density achieved is lower in comparison to that observed in artificial plasma which is most likely due to the effect the additional components in the plasma have on the cathode as the polarisation curves for the EFC (Figure 6 ) indicate that the cathode still limits the power produced in the EFC.
Others have reported on EFC operation in real samples. For example, an EFC based on direct electron transfer by cellobiose dehydrogenase enzyme at the anode and MvBOd enzyme at the cathode was operated in human serum, human plasma and human blood samples [42] , where no significant change in power output between PBS and real physiological solutions were observed, but a maximum power density of only 4 µW cm −2 obtained. A recent study on an EFC utilising FADGDH with a ferrocene redox hydrogel as bioanode and direct electron transfer at the biocathode using MvBOd immobilised onto multiwalled carbon nanotubes modified with anthracene moieties reported power densities of ~58 µW cm −2 and ~45 µW cm −2 in human serum and citrate/phosphate buffer respectively at 37 °C [7] . Ó Conghaile et al. [45] report on an EFC constructed using enzyme electrodes of Os(dmbpy)PVI, MWCNTs, and a de-glycosylated pyranose dehydrogenase at anodes and
MvBOd on a gold-nanoparticle modified electrode substrate as cathode. Power densities of up to 275 ± 50 μW cm −2 were achieved in pseudo physiological conditions, and 73 ± 7 μW cm −2 when tested in whole human blood [45, 46] .
Conclusions
Enzyme electrode components were optimised using DoE methodology for application in physiologically relevant glucose solutions. Current densities of 1. 
